by Eric Christianson | Feb 9, 2025 | Cardiovascular Medication and Disease State Clinical Pearls
This video is part of a three-part series covering new literature that could influence clinical practice. In this video, I discuss whether beta-blocker use post-MI is beneficial for patients with HFpEF. Background about the mechanism of action and typical place in...
by Eric Christianson | Jan 23, 2019 | Clinical Guideline Updates For Pharmacists
In late 2018, ACC and AHA came out with an update to their cholesterol guidelines. The last update was from 2013 so PCSK-9 inhibitors hadn’t even been approved at that time. Very High Risk Patients – My Biggest Takeaway I always had a hard time knowing...
